Literature DB >> 1452215

HLA molecules in basal cell carcinoma of the skin.

T Cabrera1, V Garrido, A Concha, J Martín, J Esquivias, M R Oliva, F Ruiz-Cabello, S Serrano, F Garrido.   

Abstract

Fifty basal cell carcinomas (BCC) and 8 samples of healthy skin were studied for HLA class I and class II antigen expression and for the presence of mutations in codon 12 of the K-ras and H-ras genes. All samples of healthy skin and of epithelium near the tumor showed high levels of class I molecules, whereas 38% of the tumors showed complete absence. Sixty-two percent of the tumors presented positive class I expression with heterogeneous staining. These losses were due to the simultaneous lack of heavy chain and beta 2-microglobulin. Selective losses of HLA-A or HLA-B antigens were not detected. Class II antigens were absent in most of the tumors, only two tumors showing a few weakly positive cells with anti-HLA-DR mAb. The loss of class I expression correlated significantly with the degree of histological differentiation and aggressiveness. We were unable to correlate class I expression with clinical size, depth of invasion or the extent of leukocytic infiltrate surrounding the tumor. Analysis by PCR amplification of codon 12 of the K-ras and H-ras oncogenes detected H-ras mutations in 1 out of 50 cases, and no K-ras mutations in any of the tumors studied. Thus, a positive relationship between K-ras and H-ras mutations and BCC tumorigenesis or MHC alterations seems unlikely in this neoplasia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452215     DOI: 10.1016/s0171-2985(11)80086-0

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  6 in total

Review 1.  MHC heterogeneity and response of metastases to immunotherapy.

Authors:  Ignacio Algarra; Federico Garrido; Angel M Garcia-Lora
Journal:  Cancer Metastasis Rev       Date:  2021-04-15       Impact factor: 9.264

2.  Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.

Authors:  Karin A Vineretsky; Margaret R Karagas; Brock C Christensen; Jacquelyn K Kuriger-Laber; Ann E Perry; Craig A Storm; Heather H Nelson
Journal:  Cancer Res       Date:  2016-01-07       Impact factor: 12.701

3.  Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma.

Authors:  J C Rockett; S J Darnton; J Crocker; H R Matthews; A G Morris
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

4.  Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade.

Authors:  Evan J Lipson; Mohammed T Lilo; Aleksandra Ogurtsova; Jessica Esandrio; Haiying Xu; Patricia Brothers; Megan Schollenberger; William H Sharfman; Janis M Taube
Journal:  J Immunother Cancer       Date:  2017-03-21       Impact factor: 13.751

Review 5.  Secretion of microvesicular miRNAs in cellular and organismal aging.

Authors:  Sylvia Weilner; Elisabeth Schraml; Heinz Redl; Regina Grillari-Voglauer; Johannes Grillari
Journal:  Exp Gerontol       Date:  2012-12-30       Impact factor: 4.032

6.  From cellular senescence to age-associated diseases: the miRNA connection.

Authors:  Elisabeth Schraml; Johannes Grillari
Journal:  Longev Healthspan       Date:  2012-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.